Tramadol Treatment for Chemotherapy-induced Mucositis Pain in Children. Issue 2 (March 2022)

• Record Type: Journal Article
• Authors: Yaffe Ornstein, Michal; Stocki, Daniel; Levin, Dror; Dvir, Rina; Manisterski, Michal; Berger-Achituv, Sivan; Rosenfeld Keidar, Hila; Peled, Yair; Hazan, Shoshana; Rosenberg, Tom; Oppenheimer, Noga; Elhasid, Ronit
• Is Part Of: Journal of pediatric hematology/oncology. Volume 44:Issue 2(2022)
• Publication Date: 2022-03
• Subjects: mucositis -- tramadol -- children -- chemotherapy -- pain; Pediatric hematology -- Periodicals; Tumors in children -- Periodicals; 618.9215
• DOI: 10.1097/MPH.0000000000002003
• Languages: English
• ISSNs: 1077-4114

Abstract

Abstract : Mucositis, a painful and debilitating condition, is a common side effect of chemotherapy. The role of tramadol in the treatment of mucositis in pediatric patients has not yet been determined. In this retrospective study, we evaluate whether tramadol as single agent achieved a reduction of pain intensity among oncologic children admitted for mucositis. In total, 34 of 54 (63%) episodes were treated with tramadol alone and achieved adequate pain relief. Tramadol's side effects were mild and manageable.